Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study

References

• Bohr J, Tysk C, Eriksson S, Abrahamsson H, Jarnerot G. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996;39:846–51.
   PubMed Web of Science ®Google Scholar
• Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut 2004;53:346–50.
   PubMed Web of Science ®Google Scholar
• Pardi DS, Loftus EV Jr, Smyrk TC, Kammer PP, Tremaine WJ, Schleck CD, The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007;56:504–8.
   PubMed Web of Science ®Google Scholar
• Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009;104:235–41; quiz 4, 42.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Madisch A, Voss C, Morgner A, Heymer P, Kuhlisch E, Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 2005;22:1115–19.
   PubMed Web of Science ®Google Scholar
• Warren BF, Edwards CM, Travis SP. ‘Microscopic colitis’: classification and terminology. Histopathology 2002;40:374–6.
   PubMed Web of Science ®Google Scholar
• Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol 1987;18:839–48.
   PubMed Web of Science ®Google Scholar
• Lazenby AJ, Yardley JH, Giardiello FM, Bayless TM. Pitfalls in the diagnosis of collagenous colitis: experience with 75 cases from a registry of collagenous colitis at the Johns Hopkins Hospital. Hum Pathol 1990;21:905–10.
   PubMedGoogle Scholar
• Nishida Y, Murase K, Isomoto H, Furusu H, Mizuta Y, Riddell RH, Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology 2002;49:678–82.
   PubMedGoogle Scholar
• Offner FA, Jao RV, Lewin KJ, Havelec L, Weinstein WM. Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol 1999;30:451–7.
   PubMed Web of Science ®Google Scholar
• Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709–50.
   PubMed Web of Science ®Google Scholar
• Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;29:1172–86.
   PubMed Web of Science ®Google Scholar
• Taha Y, Carlson M, Thorn M, Loof L, Raab Y. Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis. Dig Dis Sci 2001;46:888–97.
   PubMed Web of Science ®Google Scholar
• Peterson CG, Eklund E, Taha Y, Raab Y, Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 2002;97:1755–62.
   PubMed Web of Science ®Google Scholar
• Taha Y, Raab Y, Carlson M, Larsson A, Lordal M, Loof L, Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients. World J Gastroenterol 2006;12:7012–18.
   PubMedGoogle Scholar
• Lettesjo H, Hansson T, Peterson C, Ung KA, Ringstrom G, Abrahamsson H, Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scand J Gastroenterol 2006;41:54–9.
   PubMed Web of Science ®Google Scholar
• Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642–7.
   PubMedGoogle Scholar
• Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen A, Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflam Bowel Dis 2005;11:1085–91.
   PubMed Web of Science ®Google Scholar
• Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjo H, Carlson M. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scand J Clin Lab Investig 2007;67:810–20.
   PubMed Web of Science ®Google Scholar
• Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;58:176–80.
   PubMed Web of Science ®Google Scholar
• Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000;47:506–13.
   PubMed Web of Science ®Google Scholar
• Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15–22.
   PubMed Web of Science ®Google Scholar
• Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 2008;14:5584–9; discussion 8.
   PubMed Web of Science ®Google Scholar
• Wildt S, Rumessen JJ, Csillag C, Normark M, Poulsen KA, Kolko M. Cyclooxygenase-2 immunoreactivity in collagenous colitis. Apmis 2009;117:500–6.
   PubMed Web of Science ®Google Scholar
• Wagner M, Lampinen M, Sangfelt P, Agnarsdottir M, Carlson M. Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon. Inflamm Bowel Dis 2010;16(7):1118–26.
   Google Scholar
• Gubbins GP, Dekovich AA, Ma CK, Batra SK. Collagenous colitis: report of nine cases and review of the literature. South Med J 1991;84:33–7.
   PubMed Web of Science ®Google Scholar
• Zins BJ, Tremaine WJ, Carpenter HA. Collagenous colitis: mucosal biopsies and association with fecal leukocytes. Mayo Clin Proc 1995;70:430–3.
   PubMed Web of Science ®Google Scholar
• Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113–23.
   PubMedGoogle Scholar
• Olofsson T, Olsson I, Venge P, Elgefors B. Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol 1977;18:73–80.
   PubMedGoogle Scholar
• Brynskov J, Nielsen OH, Ahnfelt-Ronne I, Bendtzen K. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis 1994;12:290–304.
   PubMed Web of Science ®Google Scholar